HC Surgical Specialists : Annual Report FY2023 and Proposed Renewal of The Share Buy-Back Mandate Download Annual Report | Download Appendix

HC SURGICAL

SPECIALISTS

LIMITED

CUT PILES BRING SMILES

DO SCOPE

GIVES HOPE

ANNUAL REPORT 2023

TABLE OF CONTENTS

01	Corporate Profile
02	Chairman's Message
04	CEO's Statement
08	FY2023 Year In Review
10	Performance Review
12	Board of Directors
14	Key Management
15	Group Structure

This annual report has been prepared by HC Surgical Specialists Limited ("the Company") and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This annual report has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this annual report, including the correctness of any of the statements or opinions made, or reports contained in this annual report.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone [phone].

16	Our Services
24	Our Specialists
27	Our General Practitioners
30	Our Team
32	Locations of Clinics
34	Our Endoscopy Centres
35	Financial Contents
IBC	Corporate Information

CORPORATE

PROFILE

HC Surgical Specialists Limited operates a wide network of clinics

and endoscopy centres throughout Singapore, providing specialist healthcare at your doorstep in both residential

areas and central areas, making it conveniently accessible, with less waiting time and lower costs. As members of the same group, the clinics are dedicated to provide endoscopic procedures including gastroscopies and colonoscopies. Most of our clinics are equipped with the facilities to perform general surgery services with a focus on colorectal surgery procedures on site. Our endoscopy centres aim to provide maximum comfort, efficiency and safety to all our patients. Most of our clinics are also Medisave and Medishield Life accredited, enabling us to further enhance our services to our patients.

01

ANNUAL REPORT 2023

CHAIRMAN'S

MESSAGE

HCSS aims to recruit more orthopaedic surgeons to strengthen the spectrum of the Group's medical services, thereby providing patients with more comprehensive care and medical services.

02

HC SURGICAL SPECIALISTS LIMITED

CHAIRMAN'S MESSAGE

DEAR SHAREHOLDERS,

On behalf of the Directors and Management of HC Surgical Specialists Limited ("HCSS" or "Company", and together with its subsidiaries, collectively, the "Group"), I am pleased to present the Annual Report for HCSS for the fnancial year ended 31 May ("FY") 2023.

FY2023 started with a good news as the Group won the tender process and was appointed by AIA Singapore Private Limited for a second 3-year term to provide colonoscopy screening services for their eligible policy holders. This is a testament to our standard of quality medical services, and the best reward for our hard work in the frst 3-year term. To better serve our patients, we opened an endoscopy centre in the Siglap area in December 2022, thereby further expanding our network of endoscopy centres in the heartlands around Singapore.

The Group's revenue and operational profts remained relatively consistent with the previous year, despite the continuous inflationary pressures and one of the Group's surgeons, Dr. Julian Ong, being suspended for 2 years with effect from 2 December 2022. This cannot be achieved without the dedication and efforts put in by all the doctors and staff of HCSS.

MOVING FORWARD

Moving forward, we are delighted to start the new fnancial year with the addition of an orthopaedic surgeon, Dr. Benjamin Seah. Dr. Seah is an experienced surgeon, having worked in public hospitals for more than 15 years, managing complex upper limb fractures, joint replacements and ligament injuries for the hospital. The addition of Dr. Seah signifes an important step to broaden the spectrum of the Group's medical services, which is in line with the Group's long-term plans for growth. HCSS aims to recruit more orthopaedic surgeons to strengthen this segment, thereby providing patients with more comprehensive care and medical services.

APPRECIATION

Last but not least, I would like to take this opportunity to thank our Shareholders, patients and business partners for their unwavering support to HCSS, my fellow Directors for their valuable insights throughout the past years, and the staff and Management for their dedication and commitment.

03

ANNUAL REPORT 2023